Thus, it is not surprising that loss-of-function mutations in PCSK1 in humans lead to a complex set of endocrinopathies including malabsorptive diarrhea, hypogonadotropic hypogonadism, adrenal malfunction, central diabetes insipidus, and hyperphagic obesity1–5. Here, PCSK1 is linked to endocrine system disorder.